<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To present a large series of choroidal <z:hpo ids='HP_0001028'>hemangiomas</z:hpo> treated with proton beam irradiation and to describe the treatment outcomes </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We treated 54 eyes of 53 patients with choroidal <z:hpo ids='HP_0001028'>hemangioma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The lesions consisted of 48 circumscribed <z:hpo ids='HP_0001028'>hemangiomas</z:hpo> and six diffuse <z:hpo ids='HP_0001028'>hemangiomas</z:hpo> in patients with <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The total applied dose was 27.3 Gy in four eyes, 22.7 Gy in three eyes, and 16.4 Gy to 18.2 Gy in 47 eyes </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The retina reattached within six months after treatment in <z:hpo ids='HP_0000001'>all</z:hpo> 54 eyes and no recurrence of the secondary <z:hpo ids='HP_0000541'>retinal detachment</z:hpo> occurred within the follow-up period of 6 months to 9 years </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumors</z:e> treated with the higher doses regressed faster than <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> treated with the lower doses, but radiation-induced complications of the optic nerve appeared in <z:hpo ids='HP_0000001'>all</z:hpo> four eyes treated with a total dose of 27.3 Gy </plain></SENT>
<SENT sid="6" pm="."><plain>Of 31 eyes treated with 16.4 to 18.2 Gy and followed for more than 1 year, 22 had an improvement in their visual acuity, and nine retained the same visual acuity </plain></SENT>
<SENT sid="7" pm="."><plain>At the last follow-up examination, the best-corrected visual acuity was 20/20 or better in nine eyes, 20/40 to 20/25 in 13 eyes, 20/100 to 20/50 in six eyes, and 20/200 or less in three eyes </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Proton beam irradiation of choroidal <z:hpo ids='HP_0001028'>hemangiomas</z:hpo> appears to be a valid therapeutic alternative </plain></SENT>
<SENT sid="9" pm="."><plain>A total proton dose ranging from 16.4 to 18.2 Gy applied in four daily fractions seems adequate to ensure local control of both <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and secondary <z:hpo ids='HP_0000541'>retinal detachment</z:hpo> </plain></SENT>
</text></document>